Supplementary Figure 15 from A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure 15. Gene expression signatures of stemness and differentiation in the blast compartment of individual patients on UMAP projection.
Authors: Courtney D. DiNardo, Amir T. Fathi, Ashwin Kishtagari, Kapil N. Bhalla, Alfonso Quintás-Cardama, Sarah A. Reilly, Caroline Almon, Caitlin Patriquin, Salah Nabhan, Kathleen Healy, Denice Hickman, Michael P. Collins, Alexis Khalil, Dillon Corrigan, Tina Zhao, Jessica Piel, Kelly Lyons, Kim Horrigan, Virna Schuck, Paul Martin, GiNell Elliott, David L. Lahr, Mia Bosinger, Katie D’Aco, Gromoslaw Aleksander Smolen, Martin Hentemann, Sanam Loghavi, Samuel Agresta, Michael R. Savona, Eytan M. Stein
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4411284075